Genital Herpes - Epidemiology Forecast to 2027

  • ID: 4564665
  • Report
  • 54 pages
  • DelveInsight
1 of 3
‘Genital Herpes - Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Genital Herpes in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered:
  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan
Study Period:: 2016-2027

Genital Herpes Epidemiology

The Genital Herpes epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Genital Herpes is studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Genital Herpes Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total prevalent cases, gender-specific prevalent cases and total diagnosed cases) scenario of Genital Herpes in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to this research, the total prevalent population of Genital Herpes was found to be 81,556,334 in the year 2016 in 7MM.

Report Scope:
  • The report covers detailed overview of Genital Herpes explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Genital Herpes in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by type i.e., Herpes Simplex Virus 1 and Herpes Simplex Virus 2 of Genital Herpes in 7MM
Key strengths:
  • 10 Year Forecast of Genital Herpes epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of Genital Herpes
  • Prevalent Cases according to segmentation: Type prevalence i.e., HSV Type 1 and 2
  • Diagnosed cases of Genital Herpes
Key assessments:
  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Key Insights

2. Disease Background and Overview: Genital Herpes
2.1. Introduction
2.2. Pathophysiology
2.3. Causes
2.4. Risk factors
2.5. Complications
2.6. Signs and Symptoms
2.7. Clinical Manifestations
2.8. Diagnosis

3. Epidemiology and Patient Population
3.1. Key Findings
3.2. Disease Definition
3.3. Population and Forecast Parameters
3.4. 7MM Prevalent Population of Genital Herpes
3.5. Country Wise-Epidemiology of Genital Herpes
3.6. United States
3.6.1. Prevalent Population of Genital Herpes
3.6.2. Gender Specific Prevalent Population of Genital Herpes
3.6.3. Total Diagnosed Cases of Genital Herpes
3.7. Germany
3.7.1. Prevalent Population of Genital Herpes
3.7.2. Gender Specific Prevalent Population of Genital Herpes
3.7.3. Total Diagnosed Cases of Genital Herpes
3.8. France
3.8.1. Prevalent Population of Genital Herpes
3.8.2. Gender Specific Prevalent Population of Genital Herpes
3.8.3. Total Diagnosed Cases of Genital Herpes
3.9. United Kingdom
3.9.1. Prevalent Population of Genital Herpes
3.9.2. Gender Specific Prevalent Population of Genital Herpes
3.9.3. Total Diagnosed Cases of Genital Herpes
3.10. Italy
3.10.1. Prevalent Population of Genital Herpes
3.10.2. Gender Specific Prevalent Population of Genital Herpes
3.10.3. Diagnosed Cases of Genital Herpes
3.11. Spain
3.11.1. Prevalent Population of Genital Herpes
3.11.2. Gender Specific Prevalent Population of Genital Herpes
3.11.3. Diagnosed Cases of Genital Herpes
3.12. Japan
3.12.1. Prevalent Population of Genital Herpes
3.12.2. Gender Specific Prevalent Population of Genital Herpes
3.12.3. Diagnosed Cases of Genital Herpes

4. Appendix
4.1. Report Methodology

5. Capabilities

6. Disclaimer

7. About the Publisher

List of Tables
Table 1: Prevalent Population of Genital Herpes in the 7MM (2016-2027)
Table 2: Total Prevalent Population of Genital Herpes in the United States (2016-2027)
Table 3: Gender-Specific Prevalent Population of Genital Herpes in the United States (2016-2027)
Table 4: Total Diagnosed Cases of Genital Herpes in the United States (2016-2027)
Table 5: Total Prevalent Population of Genital Herpes in Germany (2016-2027)
Table 6: Gender-Specific Prevalent Population of Genital Herpes in Germany (2016-2027)
Table 7: Total Diagnosed Cases of Genital Herpes in the Germany (2016-2027)
Table 8: Prevalent Population of Genital Herpes in France (2016-2027)
Table 9: Gender-Specific Prevalent Population of Genital Herpes in France (2016-2027)
Table 10: Total Diagnosed Cases of Genital Herpes in France (2016-2027)
Table 11: Prevalent Population of Genital Herpes in the United Kingdom (2016-2027)
Table 12: Gender-Specific Prevalent Population of Genital Herpes in the United Kingdom (2016-2027)
Table 13: Total Diagnosed Cases of Genital Herpes in the United Kingdom (2016-2027)
Table 14: Prevalent Population of Genital Herpes in Italy (2016-2027)
Table 15: Gender-Specific Prevalent Population of Genital Herpes in Italy (2016-2027)
Table 16: Diagnosed Cases of Genital Herpes in Italy (2016-2027)
Table 17: Prevalent Population of Genital Herpes in Spain (2016-2027)
Table 18: Gender-Specific Prevalent Population of Genital Herpes in Spain (2016-2027)
Table 19: Diagnosed Cases of Genital Herpes in Spain (2016-2027)
Table 20: Prevalent Population of Genital Herpes in Japan (2016-2027)
Table 21: Gender-Specific Prevalent Population of Genital Herpes in Japan (2016-2027)
Table 22: Diagnosed Cases of Genital Herpes in Japan (2016-2027)

List of Figures
Figure 1: Keratin Proteins and EB Simplex involved in Pathophysiology of Herpes Simplex Virus
Figure 2: Signs and Symptoms of Genital Herpes
Figure 3: Prevalent Population of Genital Herpes in the 7MM (2016-2027)
Figure 4: Total Prevalent Population of Genital Herpes in the United States (2016-2027)
Figure 5: Gender-Specific Prevalent Population of Genital Herpes in the United States (2016-2027)
Figure 6: Total Diagnosed Cases of Genital Herpes in the United States (2016-2027)
Figure 7: Total Prevalent Population of Genital Herpes in Germany (2016-2027)
Figure 8: Gender-Specific Prevalent Population of Genital Herpes in Germany (2016-2027)
Figure 9: Total Diagnosed Cases of Genital Herpes in the Germany (2016-2027)
Figure 10: Prevalent Population of Genital Herpes in France (2016-2027)
Figure 11: Gender-Specific Prevalent Population of Genital Herpes in France (2016-2027)
Figure 12: Total Diagnosed Cases of Genital Herpes in the France (2016-2027)
Figure 13: Prevalent Population of Genital Herpes in the United Kingdom (2016-2027)
Figure 14: Gender-Specific Prevalent Population of Genital Herpes in the United Kingdom (2016-2027)
Figure 15: Total Diagnosed Cases of Genital Herpes in the United Kingdom (2016-2027)
Figure 16: Prevalent Population of Genital Herpes in Italy (2016-2027)
Figure 17: Gender-Specific Prevalent Population of Genital Herpes in Italy (2016-2027)
Figure 18: Diagnosed Cases of Genital Herpes in Italy (2016-2027)
Figure 19: Prevalent Population of Genital Herpes in Spain (2016-2027)
Figure 20: Gender-Specific Prevalent Population of Genital Herpes in Spain (2016-2027)
Figure 21: Diagnosed Cases of Genital Herpes in Spain (2016-2027)
Figure 22: Prevalent Population of Genital Herpes in Japan (2016-2027)
Figure 23: Gender-Specific Prevalent Population of Genital Herpes in Japan (2016-2027)
Figure 24: Diagnosed Cases of Genital Herpes in Japan (2016-2027)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll